Potential separation of multiple system atrophy and Parkinson's disease by susceptibility-derived components

Su Yan1, Jun Lu2, Bingfang Duan1

  • 1Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China.

Neuroimage
|April 26, 2025
PubMed
Abstract

Insights

Magnetic susceptibility MRI metrics reveal distinct pathological changes in multiple system atrophy (MSA) and Parkinson's disease (PD). These markers can differentiate between MSA and PD, aiding clinical diagnosis.

Area of Science:

  • Neuroimaging
  • Neurodegenerative diseases
  • Biomarkers

Background:

  • Multiple system atrophy (MSA) and Parkinson's disease (PD) involve iron dysregulation, demyelination, and oxidative stress.
  • Magnetic susceptibility MRI offers noninvasive insights into these alterations.
  • Clinical implications of these neurodegenerative processes remain unclear.

Purpose of the Study:

  • Investigate subcortical alterations using susceptibility-derived MRI metrics in MSA and PD.
  • Characterize differences in iron, myelin, and oxygen metabolism between these synucleinopathies.
  • Assess the potential of these metrics for clinical differentiation.

Main Methods:

  • 180 patients (122 PD, 58 MSA) and 77 healthy controls (HCs) underwent MRI.
  • Multi-echo gradient echo MRI scans were acquired.
  • Susceptibility source separation, oxygen extraction fraction (OEF) mapping, and subcortical nuclei segmentation were used.

Main Results:

  • MSA showed elevated paramagnetic and diamagnetic susceptibility in specific nuclei and reduced OEF compared to PD and HCs.
  • PD exhibited distinct susceptibility changes in the substantia nigra and globus pallidus.
  • Susceptibility metrics effectively distinguished PD from MSA (AUC=0.833) and correlated with disease severity.

Conclusions:

  • Susceptibility-derived MRI metrics can detect distinct pathological involvement in MSA and PD.
  • These noninvasive markers hold significant potential for differentiating between MSA and PD in clinical practice.
  • Further research can leverage these findings for improved diagnostic strategies.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
266